Clinical Trials Sponsored by 1E Therapeutics
Total 6303 results
-
University of North Carolina, Chapel HillMidmark Corporation; Monitored Therapeutics, IncCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Johns Hopkins UniversityUniversity of Wisconsin, Madison; Frantz Viral Therapeutics, LLCCompletedPrecancerous Conditions | Human Papilloma Virus | Anal Dysplasia | HPV-Related Anal Intraepithelial Neoplasia | AIN2/3 | Artesunate | Alternative TreatmentUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...Orchard TherapeuticsCompletedAdenosine Deaminase Deficiency | Severe Combined Immunodeficiencies (SCID)United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
PTC TherapeuticsCystic Fibrosis Foundation; ECFS-Clinical Trial Network (ECFS-CTN)CompletedCystic FibrosisUnited States, Spain, United Kingdom, Netherlands, Germany, France, Belgium, Italy, Australia, Argentina, Brazil, Bulgaria, Canada, Greece, Israel, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
Imperial College LondonSarepta Therapeutics, Inc.; Department of Health, United KingdomCompletedDuchenne Muscular DystrophyUnited Kingdom
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.Withdrawn
-
Wake Forest UniversityEKR Therapeutics, IncTerminatedHip ArthroplastyUnited States
-
PfizerRoswell Park Cancer Institute; South Texas Accelerated Research Therapeutics...CompletedAdvanced Malignant Solid TumorsUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.CompletedMalignant Glioma | WHO Grade III or IV Recurrent GliomaUnited States
-
Erin BertinoKaryopharm Therapeutics IncWithdrawnRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
Shanxi Province Cancer HospitalShanghai Ultra-T Immune Therapeutics Co. LTDRecruitingAcute Lymphocytic Leukemia， B-CellChina
-
CARsgen Therapeutics Co., Ltd.Fudan University; Peking University Cancer Hospital & InstituteRecruitingStudy to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionPancreatic Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Elusys TherapeuticsCenters for Disease Control and Prevention; APCER Life SciencesNot yet recruitingInfection, Bacterial | Anthrax
-
Dana-Farber Cancer InstituteVascular Biogenics Ltd. operating as VBL TherapeuticsActive, not recruitingGlioblastoma | Recurrent GlioblastomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMinneamrita Therapeutics LLCTerminatedAcute Myeloid LeukemiaUnited States
-
National Institute of Allergy and Infectious Diseases...Sanofi; ModeX TherapeuticsTerminated
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, IncTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditionsUnited States
-
Pronacera Therapeutics SLCentre for the Development of Industrial Technology, SpainActive, not recruiting
-
Edward Lain, MDVyne Therapeutics Inc.CompletedAcne VulgarisUnited States
-
Hartford HospitalNational Institute of Mental Health (NIMH); Oui Therapeutics, Inc.CompletedSuicidal Ideation | Suicide, AttemptedUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...Orchard TherapeuticsCompletedSevere Combined Immunodeficiency Due to ADA DeficiencyUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncTerminatedHepatocellular CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Frantz Viral TherapeuticsCompletedCervical Intraepithelial Neoplasia Grade 2/3 | High-risk HPV (Any Strain)United States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
SPR Therapeutics, Inc.United States Department of Defense; NDI Medical, LLCCompletedPhantom Limb Pain | Residual Limb Pain | Post-Amputation PainUnited States
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Bhavana BhatnagarKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
University of North Carolina, Chapel HillWindtree Therapeutics; Cystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
ImmunoBiology LimitedSimbec Research; ORION Clinical Services; Oxford Therapeutics Consulting LimitedCompletedPneumococcal InfectionUnited Kingdom
-
Erin BertinoKaryopharm Therapeutics IncTerminatedRecurrent Small Cell Lung CarcinomaUnited States
-
Silence Therapeutics GmbHFGK Clinical Research GmbH; Granzer Regulatory Consulting & ServicesCompletedCarcinoma, Pancreatic DuctalGermany
-
VistaGen Therapeutics, Inc.National Institute on Drug Abuse (NIDA); Cato ResearchCompletedNeuropathic PainUnited States
-
Musli Thyropeutics Ltd.Tel-Aviv Sourasky Medical CenterTerminatedGlioblastoma Multiforme (GBM)Israel
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
Ottawa Hospital Research InstituteRespironics, California, Inc.; Therapeutic Monitoring SystemsCompletedCritical IllnessCanada
-
Frantz Viral Therapeutics, LLCAnal Dysplasia Clinic MidWest; Laser Surgery Care, LLCRecruitingAnal High-grade Squamous Intraepithelial Lesion | Anal HSIL | Anal HPV InfectionUnited States
-
Zhang Xiaofeng,MDZeno Therapeutics Pte. LtdNot yet recruitingPancreatic Cancer | Advanced Biliary Cancer
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
April Salama, M.D.Merck Sharp & Dohme LLC; Olatec Therapeutics LLCRecruiting
-
Ottawa Hospital Research InstituteOntario Institute for Cancer Research; Intensity Therapeutics, Inc.Recruiting
-
Fundamenta Therapeutics, Ltd.The First Affiliated Hospital of USTC (Anhui Provincial Hospital)RecruitingB Cell MalignancyChina
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Candel Therapeutics, Inc.RecruitingGlioma | Glioblastoma | Astrocytoma | Malignant Glioma of Brain | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | Ependymoma | Ganglioglioma | Oligodendroglioma | Malignant Astrocytoma | Anaplastic Oligodendroglioma of Brain (Diagnosis) | Mixed Oligo-Astrocytoma | Pylocytic/Pylomyxoid AstrocytomaUnited States
-
Ki Health Partners. LLCRevance Therapeutics, Inc.; The Los Angeles Headache CenterActive, not recruitingMigraine DisordersUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Affini-T Therapeutics, Inc.Active, not recruiting